During the past decade, Mazda Hospital of Mazda Motor Corporation conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mazda Hospital of Mazda Motor Corporation" are "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Cough" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Mazda Hospital of Mazda Motor Corporation" in a lesser frequency.

Most popular intervention types in "Mazda Hospital of Mazda Motor Corporation" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mazda Hospital of Mazda Motor Corporation" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Mazda Hospital of Mazda Motor Corporation". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mazda Hospital of Mazda Motor Corporation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mazda Hospital of Mazda Motor Corporation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".